文献速递关节外科

捆绑支付是人工关节翻修术可行的报销模式吗?

Are Bundled Payments a Viable Reimbursement Model for Revision Total Joint Arthroplasty?
PubMed 文献 · Clin Orthop Relat Res · 2016-06-29

本研究在一个医疗系统内回顾218例(分析217例)翻修全髋或全膝关节置换术患者,比较实施CMS捆绑支付改进计划(BPCI)前后费用、住院时长和再入院率等。结果显示捆绑组住院时长更短、住院报销更低,但总诊疗期费用无差异;翻修髋与翻修膝费用无差异;康复机构去向、住院≥4天和90天内再入院是高费用独立危险因素。作者认为捆绑支付可能成为翻修TJA可行的报销模式,但需未来研究确定能否改善医疗并降低费用。

要点

  • 捆绑支付组住院时长平均4.02天(SD 3.0)短于非捆绑组平均5.27天(SD 3.6),p=0.001。
  • 捆绑组住院报销平均17754美元(SD 2741)低于非捆绑组平均18316美元(SD 4732),p=0.030。
  • 康复机构去向、住院≥4天、90天内再入院是高费用诊疗期的独立危险因素。

核心结论

  • 捆绑支付有潜力成为翻修全关节置换术可行的报销模式。
  • 由于手术过程不可预测、并发症固有高风险和手术复杂程度不同,需未来研究确定捆绑翻修TJA患者能否改善医疗并降低费用。

研究设计与样本

  • 回顾性分析2013年10月至2015年3月在一个医疗系统内接受翻修全膝或全髋关节置换术的218例患者,排除1例血友病离群值后分析217例。
  • 研究期间该机构启动翻修TJA的BPCI计划,2014年1月1日(一家医院)和2015年1月1日(另一家医院)前的手术未纳入捆绑支付安排(70例翻修TKA和56例翻修THA),50例翻修TKA和41例翻修THA在BPCI下实施。
  • 比较捆绑组与非捆绑组的人口学、合并症、CMS诊疗期报销数据、住院时长和再入院比例。

主要发现

  • 捆绑支付安排前手术组住院时长平均5.27天(SD 3.6)长于BPCI组平均4.02天(SD 3.0),p=0.001。
  • 捆绑组住院报销平均17754美元(SD 2741)低于非捆绑组平均18316美元(SD 4732),p=0.030。
  • 两组总诊疗期CMS费用无差异(捆绑组平均38107美元[SD 18328] vs 非捆绑组平均37851美元[SD 17208]),p=0.984。
  • 翻修髋与翻修膝的总诊疗期CMS费用无差异(翻修髋平均38627美元[SD 18607] vs 翻修膝平均37414美元[SD 16884]),p=0.904。
  • 康复机构去向(OR 5.49;95%CI 1.97-15.15;p=0.001)、住院时长≥4天(OR 3.66;95%CI 1.60-8.38;p=0.002)和90天内再入院(OR 6.99;95%CI 2.58-18.91;p<0.001)是高费用诊疗期的独立危险因素。

临床怎么用

  • 作者认为捆绑支付有潜力成为翻修TJA可行的报销模式。
  • 作者指出由于手术不可预测、并发症高风险和手术复杂度不同,需未来研究确定捆绑翻修TJA患者能否改善医疗并降低费用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alternative payment models, such as the Centers for Medicare & Medicaid Services (CMS) Bundled Payment for Care Improvement (BPCI) initiative, aim to decrease overall costs for hip and knee arthroplasties. QUESTIONS/PURPOSES: We asked: (1) Is there any difference in the CMS episode-of-care costs, hospital length of stay, and readmission rate from before and after implementation of our bundled-payment program? (2) Is there any difference in reimbursements and resource utilization between revision THA and TKA at our institution? (3) Are there any independent risk factors for patients with high costs who may not be appropriate for a bundled-payment system for revision total joint arthroplasty (TJA)? METHODS: Between October 2013 and March 2015, 218 patients underwent revision TKA or THA in one health system. Two hundred seventeen patients were reviewed as part of this study, and one patient with hemophilia was excluded from the analysis as an outlier. Our institution began a BPCI program for revision TJA during this study period. Patients' procedures done before January 1, 2014 at one hospital and January 1, 2015 at another hospital were not included in the bundled-care arrangement (70 revision TKAs and 56 revision THAs), whereas 50 revision TKAs and 41 revision THAs were performed under the BPCI initiative. Patient demographics, medical comorbidities, episode-of-care reimbursement data derived directly from CMS, length of stay, and readmission proportions were compared between the bundled and nonbundled groups. RESULTS: Length of stay in the group that underwent surgery before the bundled-care arrangement was longer than for patients whose procedures were done under the BPCI (mean 4.02 [SD, 3.0 days] versus mean 5.27 days [SD, 3.6 days]; p = 0.001). Index hospitalization reimbursement for the bundled group was less than for the nonbundled group (mean USD 17,754 [SD, USD 2741] versus mean USD 18,316 [SD, USD 4732]; p = 0.030). There was no difference, with the numbers available, in total episode-of-care CMS costs between the two groups (mean USD 38,107 [SD, USD 18,328] versus mean USD 37,851 [SD, USD 17,208]; p = 0.984). There was no difference, with the numbers available, in the total episode-of-care CMS costs between revision hip arthroplasties and revision knee arthroplasties (mean USD 38,627 [SD, USD 18,607] versus mean USD 37,414 [SD, USD 16,884]; p = 0.904). Disposition to rehabilitation (odds ratio [OR], 5.49; 95% CI, 1.97-15.15; p = 0.001), length of stay 4 days or greater (OR, 3.66; 95% CI, 1.60-8.38; p = 0.002), and readmission within 90 days (OR, 6.99; 95% CI, 2.58-18.91; p < 0.001) were independent risk factors for high-cost episodes. CONCLUSIONS: Bundled payments have the potential to be a viable reimbursement model for revision TJA. Owing to the unpredictable nature of the surgical procedures, inherent high risks of complications, and varying degrees of surgical complexity, future studies are needed to determine whether bundling patients having revision TJA will result in improved care and decreased costs. LEVEL OF EVIDENCE: Level IV, economic and decision analysis.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Courtney PM, Ashley BS, Hume EL, et al. Are Bundled Payments a Viable Reimbursement Model for Revision Total Joint Arthroplasty? Clin Orthop Relat Res. 2016. PMID: 27357691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。